Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia

Phase 4

Not yet recruiting

• Conditions: Pregnancy Anemia; Anemia, Iron Deficiency
• Interventions: Drug: Venofer 200 MG Per 10 ML Injection; Drug: Ferinject

• Registration Number: NCT06061393
• Lead Sponsor: Western Galilee Hospital-Nahariya

Brief Summary

The purpose of this study is to compare maternal outcomes such as increased hemoglobin need for blood transfusion and hemoglobin level before and post partum in women with hemoglobin \<9 gr/dl , treated with venofer and women treated with ferinject.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2023-09-24
• Study First Submitted QC: 2023-09-24
• Study First Posted: 2023-09-29
• Status Verified: 2023-10
• Last Update Submitted: 2023-10-04
• Last Update Posted: 2023-10-06
• Study Start: 2023-10-30
• Primary Completion: 2025-09-20
• Study Completion: 2025-09-20

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

pregnancy>24 weeks of gestation anemia with Hb<8 anemia with Hb<9 if symptomatic anemia of previous postpartum hemorrhage

Exclusion Criteria

• Allergy to one of the study's drugs
• IV iron treatment in the last month
• chronic anemia- thalassemia, renal failure Twins pregnancy
• non iron deficiency anemia

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
venofer	Venofer 200 MG Per 10 ML Injection	Women with iron def. anemia aith hemoglobin level \<9 gr/dl who will be traeted with venofer
Ferinject	Ferinject	Women with iron def. anemia aith hemoglobin level \<9 gr/dl who will be traeted with ferinject

Primary Outcome Measures

Name	Time	Method
postpartum Hb level	during 48 hours after delivery	gr/dl
ratio of women with Hb level >11 at delivery	at delivery	Hb level